Pharmaceutical Raw Materials Fladrafinil / CRL-40,941 CAS 90212-80-9

White Powder Nootropics Smart Drugs Powder Aniracetam CAS 90212-80-9

What is Fladrafinil:
Fladrafinil is also referred to as CRL-40,941 or fluorafinil. It is a wakefulness-promoting agent that is found in the eugeroic classification of drugs. Fladrafinil is closely related to adrafinilandmodafinil. Though it’s chemical composition and effects are very similar, it is capable of producing anti-aggressive effects while adrafinildoesn’t have this ability. Fladrafinil is the bis(p-fluoro) ring-substituted derivative ofadrafinil. It promotes wakefulness and thought acceleration. It increases cognitive function, motivation, and improves memory as it works on dopamine and histamine neurotransmitters in the brain.

Fladrafinil effects:
The drug is reported to have little or no side effects when taken at the correct dose over a short period of time. Fladrafinil is ONLY designed and intended for short term use. Long-term use and misuse of the drug can affect our brain in many ways. This medicine blocks the reuptake of dopamine and norepinephrine in the presynaptic cleft immediately upon being released. Long-term use of the drug causes lesions on cerebral blood pathways and brain injury affects the efficiency of neurotransmitter substances in our brain.

Fladrafinil dosage:
Fladrafinil is 3-4 more potent thanadrafinil. New users should start with 30-80 mgs within 14-16 hours daily, and anadrafinil moderate dose is between 30-100 mg par jour. The dosage to be increased as the effects are being experienced as the body reacts towards the dose. Dosage should not exceed 200mgs per day.